Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
45.02
-0.18 (-0.40%)
Dec 5, 2025, 4:00 PM EST - Market closed
Scholar Rock Holding Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
128
Market Cap
4.59B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SRRK News
- 3 days ago - Scholar Rock Holding Corporation (SRRK) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 3 days ago - Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away - The Motley Fool
- 18 days ago - Scholar Rock to Present at Upcoming Investor Conferences - Business Wire
- 22 days ago - Scholar Rock Holding Corporation (SRRK) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Scholar Rock Reports Third Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 23 days ago - Looking For A Squeeze? Here Are The Top 10 Most Shorted Stocks - Benzinga
- 24 days ago - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 26 days ago - Scholar Rock: De-Risked Biotech, Playing The Approval Catalyst (Buy Rating) - Seeking Alpha